Susquehanna International Group, LLP Sellas Life Sciences Group, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2025 Aug 14, 2025	BUY	$1.04 - $2.19 $27,352 - $57,597	26,300 New	26,300 $57,000
Q4 2024 Feb 14, 2025	BUY	$0.84 - $1.35 $17,640 - $28,350	21,000 New	21,000 $21,000
Q2 2024 Aug 15, 2024	BUY	$1.06 - $1.63 $22,790 - $35,045	21,500 Added 93.07%	44,600 $53,000
Q1 2024 May 07, 2024	SELL	$0.51 - $1.55 $3,723 - $11,315	-7,300 Reduced 24.01%	23,100 $23,000
Q4 2023 Feb 14, 2024	BUY	$0.88 - $1.57 $26,752 - $47,728	30,400 New	30,400 $32,000
Q1 2023 May 16, 2023	SELL	$1.18 - $3.86 $944 - $3,088	-800 Reduced 7.02%	10,600 $15,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $5.41 $24,120 - $72,494	-13,400 Reduced 54.03%	11,400 $26,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.38 $12,524 - $20,956	-6,200 Reduced 20.0%	24,800 $50,000

22.6M

1.3M

59.3K

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $41.9M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.